[Androgen synthesis inhibitors and new androgen receptor antagonists].
Division of Urology, Department of Regenerative and Transplant Medicine, Niigata University Graduate School of Medical and Dental Sciences.
Tsutomu
T
Nishiyama
D000069501:Abiraterone Acetate; D059002:Androgen Receptor Antagonists / Q000627:therapeutic use*; D000728:Androgens / Q000096:biosynthesis*; D000730:Androstadienes / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011966:Receptors, LHRH / Q000037:antagonists & inhibitors; D013254:Steroid 17-alpha-Hydroxylase / Q000037:antagonists & inhibitors
D059002:Androgen Receptor Antagonists; D000728:Androgens; D000730:Androstadienes; C484844:GNRHR protein, human; D011966:Receptors, LHRH; C501892:CYP17A1 protein, human; D013254:Steroid 17-alpha-Hydroxylase; D000069501:Abiraterone Acetate